在患有异常性炎症性肌肉病症的患者中,血栓事件的预测因素
Sangmee Sharon Bae1, Jennifer Wang2, Ani Shahbazian2
1Division of Rheumatology, University of California Los Angeles, David Geffen School of Medicine, Los Angeles, CA, USA. sbae@mednet.ucla.edu.
Clinical and experimental rheumatology
|July 14, 2025
概括
异形性炎症性肌肉病 (IIM) 患者面临血栓事件,早期有静脉问题,后来有动脉事件. 在高风险人群中,PON1活动预测动脉事件.
科学领域:
- 类风湿病学 类风湿病学
- 心血管医学 心血管医学
- 临床流行病学临床流行病学
背景情况:
- 异形性炎症性肌肉病变 (IIM) 是一种罕见的自身免疫性疾病,伴有并发症风险增加.
- 血栓事件,包括动脉 (ATE) 和静脉 (VTE) 类型,是IIM患者的重大并发症.
- 预测和理解这些事件的时间对于患者管理至关重要.
研究的目的:
- 在一组患有异常性炎症性肌肉病变 (IIM) 的患者中确定血栓事件的预测因素.
- 分析 IIM 中动脉和静脉血栓事件 (ATE 和 VTE) 的发生率和时间模式.
- 研究特定因素 (包括PON1活性) 在预测血栓形成风险方面的作用.
主要方法:
- 来自单个学术中心的纵向IIM队列的回顾性分析.
- 用于估计ATE和VTE的发病率比率 (IRR) 的Poisson回归模型.
- 评估传统的心血管风险因素,疾病活性,损伤以及PON1乳酶活性.
主要成果:
- 在312名IIM患者中,12%的患者在中位数6年的随访期间经历了血栓事件.
- 主要发生在诊断后3年内 (65%的事件),而ATE发生在晚些时候 (41%在10年后).
- 短暂的疾病持续时间 (<1年) 预测了VTE;以前的ATE预测了未来的ATE. 在高心血管风险患者中,PON1活动预测了ATE.
结论:
- 本研究详细介绍了IIM中血栓事件的发生率和危险因素,重点是早期VTE和晚期ATE.
- 疾病持续时间和先前的ATE分别是VTE和ATE的关键预测指标.
- 在高危IIM患者中,PON1乳酶活性为ATE提供了额外的预测价值.
相关概念视频
Myocarditis II: Clinical Features and Diagnostic Tests
25
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
25
Myasthenia Gravis: Diagnostic Tests
1.4K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.4K
Myocarditis III: Medical Management
17
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
17
Myocarditis I: Introduction
34
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
34
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
426
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
426
Inflammatory Bowel Disease IV: Pharmacological Management
198
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
198


